Whilst I take absolutely no pleasure in reading stories about how previously high-flying companies have hit the skids, it will be interesting to understand how things at Theranos were able to get quite as out of hand as they clearly were. 

Elizabeth Holmes must be a very impressive character - to be aged under 30 and own a majority share in a company valued at over $9bn is nothing short of remarkable. She was able to bring in some very respected investors that invested a total of $724m, and surrounded herself with pillars of the technology and medical communities as advisors. How then, did things unravel quite so spectacularly? It will be interesting to read the reports as they surface - lets hope its not in the form of a post-mortem.